Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
Vishwajith Sridharan(Massachusetts General Hospital), Jonathan D. Schoenfeld(Brigham and Women's Hospital)
Cited by 84
Related Papers
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
|JAMA Oncology|2020|340
Multicenter Evaluation of Radiation and Immune Checkpoint Inhibitor Therapy in Mucosal Melanoma and Review of Recent Literature
|Advances in Radiation Oncology|2023|16
FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with <i>FGFR2</i> Fusion Status and Immune Signatures
|Clinical Cancer Research|2022|14